- $2.87bn
- $2.35bn
- $926.20m
- 71
- 76
- 98
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 567 | 600 | 730 | 795 | 797 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 527 | 429 | 796 | 768 | 736 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 239 | 116 | 428 | 448 | 397 |
Provision for Income Taxes | |||||
Net Income After Taxes | 167 | 102 | 281 | 305 | 303 |
Net Income Before Extraordinary Items | |||||
Net Income | 167 | 102 | 281 | 305 | 303 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 165 | 99.6 | 277 | 305 | 303 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.797 | 0.586 | 1.4 | 1.59 | 1.7 |
Dividends per Share |